Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.99.75 CHF
Change Today -0.45 / -0.45%
Volume 1.8M
NOVN On Other Exchanges
Symbol
Exchange
Xetra
New York
OTC US
Mexico
SIX Swiss Ex
SIX Swiss Ex
Frankfurt
As of 10:13 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James S. Shannon BSc, M.D., MRCP (UK)

Former Head of Pharma Development, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 12 different industries.

See Board Relationships
59--

Background*

Dr. James S. Shannon, BSc, M.D., MRCP (UK) has been the Chief Medical Officer of GlaxoSmithKline plc since May 1, 2012. Dr. Shannon served as the Chief Executive Officer and President of Cerimon Pharmaceuticals, Inc., from January 2009 to April 2010. Dr. Shannon served as Global Head of Development at Novartis Pharma AG (a division within Novartis AG) from 2005 to 2008. He joined Cerimon in December 2008. Dr. Shannon served in various executive roles at Novartis AG from ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

2015-Present
Director and Member of Compensation Committee

Education*

BS 1977
Queen’s University of Belfast
MD 1986
Queen’s University of Belfast

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.99.75 CHF -0.45

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.4M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.